Replies to post #500671 on Anavex Life Sciences Corp (AVXL)

[investingdog]

Oh, absolutely, because nothing screams 'successful drug launch' like relying on the endless patience of shorts to keep the stock pitifully controlled for a 'while.' And of course, Blarcamesine will definitely just casually ramp up sales after all the FDA nods, like it’s just another over-the-counter eye drop for millions waiting to happen. Meanwhile, the stock’s just casually hanging out in single digits, no pressure, just a modest 'Strong Buy' rating and a price target tripling from here. Slow and steady, right? Totally not the plan to explode overnight or anything.

[Hoskuld]

Molleone, there is no way that the stock price can be controlled to prevent significant appreciation subsequent to EMA approval of blarcasemine. Maybe the extent of that appreciation can be controlled. But there is no way that tier one pharma companies will not be lining up to partner with or buy Anavex upon that event.

This narrative that approval will be irrelevant to the share price is now being pushed by a few people here. Interesting.